Panobinostat can enhance the curative activity of trastuzumab in anti-HER2 refractory breast tumors by immune mediated mechanisms Conference Paper uri icon

authors

  • Medon, M
  • Jenkins, MR
  • Ramsbottom, KM
  • Smyth, MJ
  • Atadja, PW
  • Henderson, MA
  • Johnstone, RW
  • Haynes, NM

publication date

  • August 1, 2016